Cochrane · systematic review · CD011161
Sun protection for preventing basal cell and squamous cell skin cancers
Sánchez, G, Nova, J, Rodriguez‐Hernandez, AE, et al. · Cochrane Database of Systematic Reviews · 2016 · Cochrane Library
SkinAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
3
current version
GRADE rated
3
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 3 · 100%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Daily application of sunscreen compared with discretionary use for preventing basal cell and cutaneous squamous cell skin cancers
Population: general participants
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Basal cell carcinoma Confirmed clinically or by histopathology Daily application of sunscreen vs discretionary use | RR 1.03 [0.74, 1.43] | 1 study · 1621 participants | Low Downgraded: indirectness |
Cutaneous squamous cell carcinoma Confirmed clinically or by histopathology Daily application of sunscreen vs discretionary use | RR 0.88 [0.5, 1.54] | 1 study · 1621 participants | Low Downgraded: indirectness |
Adverse events Number of participants with adverse events Daily application of sunscreen vs discretionary use | no estimate extracted | 1 study · 1621 participants | Low Downgraded: indirectness |